Previous studies revealed that that adiponectin presents anti-proliferative properties in prostate cancer cells and inhibits dihydrotestosterone-activated cell proliferation, IL-6, and IGF-I [61,62,63]. This evidence concerns the gene ADIPOQ and prostate cancer.